HK1225744A1 - 製備高純度的肉毒桿菌毒素神經毒性組分的方法及其應用 - Google Patents

製備高純度的肉毒桿菌毒素神經毒性組分的方法及其應用

Info

Publication number
HK1225744A1
HK1225744A1 HK16113961A HK16113961A HK1225744A1 HK 1225744 A1 HK1225744 A1 HK 1225744A1 HK 16113961 A HK16113961 A HK 16113961A HK 16113961 A HK16113961 A HK 16113961A HK 1225744 A1 HK1225744 A1 HK 1225744A1
Authority
HK
Hong Kong
Prior art keywords
preparing
botulinum toxin
highly pure
neurotoxic component
pure neurotoxic
Prior art date
Application number
HK16113961A
Other languages
English (en)
Inventor
Michael Pfeil
Andreas Wiesenburg
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of HK1225744A1 publication Critical patent/HK1225744A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893Botulinum neurotoxin (3.4.24.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M37/00Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK16113961A 2013-07-30 2016-12-07 製備高純度的肉毒桿菌毒素神經毒性組分的方法及其應用 HK1225744A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13003792 2013-07-30

Publications (1)

Publication Number Publication Date
HK1225744A1 true HK1225744A1 (zh) 2017-09-15

Family

ID=48906087

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16113961A HK1225744A1 (zh) 2013-07-30 2016-12-07 製備高純度的肉毒桿菌毒素神經毒性組分的方法及其應用

Country Status (13)

Country Link
US (2) US9937245B2 (zh)
EP (1) EP3027641A1 (zh)
JP (1) JP6517800B2 (zh)
KR (1) KR102272580B1 (zh)
CN (1) CN105658662B (zh)
AU (1) AU2014298922B2 (zh)
BR (1) BR112016001730B1 (zh)
CA (1) CA2918233C (zh)
HK (1) HK1225744A1 (zh)
IL (1) IL243573B (zh)
MX (1) MX2016001220A (zh)
RU (1) RU2663136C2 (zh)
WO (1) WO2015014487A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
JP6517800B2 (ja) * 2013-07-30 2019-05-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ボツリヌス毒素の高純度神経毒成分の製造方法とその使用
SG11201705019PA (en) * 2014-12-23 2017-07-28 Merz Pharma Gmbh & Co Kgaa Botulinum toxin prefilled container
ES2944139T3 (es) 2015-03-26 2023-06-19 Vensica Medical Ltd Administración de fármacos ultrasónica a vejiga urinaria
EP3773262A4 (en) 2018-04-01 2022-01-19 Vensica Medical Ltd. SYSTEM AND METHOD FOR ULTRASONIC DELIVERY OF THERAPEUTIC AGENTS TO THE BLADDER
JP6875318B2 (ja) * 2018-04-24 2021-05-19 株式会社日立産機システム 安全キャビネット

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
RU2206337C1 (ru) * 2002-10-29 2003-06-20 Общество с ограниченной ответственностью "Токсины и сопутствующие продукты" Лекарственный препарат для лечения мышечных дистоний и способ его получения
US7339671B2 (en) * 2004-01-20 2008-03-04 Hong Peng Apparatus and method for monitoring biological cell culture
ES2326916T3 (es) * 2005-06-17 2009-10-21 MERZ PHARMA GMBH & CO. KGAA Aparato y metodo para la produccion de compuestos biologicamente activos por fermentacion.
WO2007059528A2 (en) * 2005-11-17 2007-05-24 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
EP2337790B1 (en) * 2008-08-29 2016-07-13 Merz Pharma GmbH & Co. KGaA Clostridial neurotoxins with altered persistency
EP2248518B1 (en) * 2009-04-17 2013-01-16 Merz Pharma GmbH & Co. KGaA Formulation for stabilizing proteins, peptides or mixtures thereof.
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP2011074025A (ja) * 2009-09-30 2011-04-14 Chemo-Sero-Therapeutic Research Inst ボツリヌス毒素の精製方法
PT2490986T (pt) * 2009-10-21 2018-11-13 Revance Therapeutics Inc Métodos e sistemas para purificar neurotoxina botulínica não complexada
US20120189677A1 (en) * 2011-01-20 2012-07-26 Stephen Tonge Formulations
FR2981386B1 (fr) * 2011-10-14 2014-08-22 Getinge La Calhene Mecanisme de commande a haut niveau de securite pour un dispositif de transfert etanche entre deux volumes clos
JP6517800B2 (ja) * 2013-07-30 2019-05-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ボツリヌス毒素の高純度神経毒成分の製造方法とその使用

Also Published As

Publication number Publication date
AU2014298922B2 (en) 2018-03-15
US20160175407A1 (en) 2016-06-23
JP2016527257A (ja) 2016-09-08
RU2663136C2 (ru) 2018-08-01
KR102272580B1 (ko) 2021-07-05
WO2015014487A1 (en) 2015-02-05
RU2016103329A (ru) 2017-08-31
US20180147266A1 (en) 2018-05-31
US9937245B2 (en) 2018-04-10
US10653754B2 (en) 2020-05-19
AU2014298922A1 (en) 2016-02-18
CN105658662B (zh) 2022-05-27
BR112016001730B1 (pt) 2023-04-11
CA2918233A1 (en) 2015-02-05
IL243573A0 (en) 2016-03-31
JP6517800B2 (ja) 2019-05-22
CA2918233C (en) 2022-08-30
EP3027641A1 (en) 2016-06-08
MX2016001220A (es) 2016-05-24
BR112016001730A2 (pt) 2017-08-29
KR20160036581A (ko) 2016-04-04
IL243573B (en) 2019-03-31
CN105658662A (zh) 2016-06-08

Similar Documents

Publication Publication Date Title
HRP20180679T1 (hr) Postupak proizvodnje botukinskog toksina
HK1225744A1 (zh) 製備高純度的肉毒桿菌毒素神經毒性組分的方法及其應用
IL242695B (en) Apparatus for production of molybdenum-99
PL3563793T3 (pl) Aparat ortodontyczny oraz sposób jego wytwarzania
EP3009021A4 (en) Glove and production process therefor
PT3461240T (pt) Processos, sistemas e aparelhos para a produção de tecnécio- 99m por um ciclotrão
EP2975149A4 (en) H-SHAPED STEEL AND METHOD FOR PRODUCING THE SAME
GB201309173D0 (en) Novel process and product
EP2980680A4 (en) TOUCH SENSOR AND MANUFACTURING METHOD THEREFOR
IL240748A0 (en) Methods for generating adenovirus
EP2965733A4 (en) PORTABLE ARTICLE AND METHOD OF MANUFACTURING THE SAME
EP2974766A4 (en) BALLOON AND PROCESS FOR PRODUCING THE SAME
GB201301639D0 (en) Product and process
ZA201507023B (en) Method and plant for the production of methane
SG11201507353RA (en) Method for the production of ethylene oxide
EP2985113A4 (en) PRODUCTION PLANT
PL2965172T3 (pl) Proces wykonania interfejsu audio-wizualnego
EP2987470A4 (en) ENDOPROTHESIS AND METHOD FOR PRODUCING SAME
SG11201507469RA (en) Processes for producing sovaprevir
EP2975160A4 (en) HOT-PRESSED ELEMENT AND MANUFACTURING METHOD THEREFOR
HK1217323A1 (zh) 異己糖醇單三氟甲磺酸酯及其合成方法
ZA201600611B (en) Process for enhanced pre-reduction of chromite
EP3083251C0 (de) Vorrichtung und verfahren zur herstellung von strukturierten oberflächen
HUE057421T2 (hu) Mikroorganizmus O-szukcinilhomoszerin elõállítására és eljárás O-szukcinilhomoszerin elõállítására annak alkalmazásával
GB201322303D0 (en) Production process